108 related articles for article (PubMed ID: 21396303)
41. A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q 12.2.
Nishioka N; Yashiro M; Inoue T; Matsuoka T; Ohira M; Chung KH
Int J Oncol; 2001 Feb; 18(2):317-22. PubMed ID: 11172598
[TBL] [Abstract][Full Text] [Related]
42. Molecular staging for survival prediction of colorectal cancer patients.
Eschrich S; Yang I; Bloom G; Kwong KY; Boulware D; Cantor A; Coppola D; Kruhøffer M; Aaltonen L; Orntoft TF; Quackenbush J; Yeatman TJ
J Clin Oncol; 2005 May; 23(15):3526-35. PubMed ID: 15908663
[TBL] [Abstract][Full Text] [Related]
43. Allelic status of chromosomes 17p, 18q, 22q [corrected] 3p and their clinical usefulness in colorectal cancer.
Fujita S; Baba H; Yamamoto S; Akasu T; Moriya Y; Sugano K
Anticancer Res; 2006; 26(4B):2833-40. PubMed ID: 16886602
[TBL] [Abstract][Full Text] [Related]
44. Genetic alteration of p53, but not overexpression of intratumoral p53 protein, or serum p53 antibody is a prognostic factor in sporadic colorectal adenocarcinoma.
Chang SC; Lin JK; Lin TC; Liang WY
Int J Oncol; 2005 Jan; 26(1):65-75. PubMed ID: 15586226
[TBL] [Abstract][Full Text] [Related]
45. Tumor progression and loss of heterozygosity at 5q and 18q in non-small cell lung cancer.
Fong KM; Zimmerman PV; Smith PJ
Cancer Res; 1995 Jan; 55(2):220-3. PubMed ID: 7812947
[TBL] [Abstract][Full Text] [Related]
46. [Refined deletion mapping of loss of heterozygosity on 22q13 in sporadic colorectal carcinoma].
Zheng HT; Tang HM; Peng ZH; Zhou CZ; He L
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):157-60. PubMed ID: 16555160
[TBL] [Abstract][Full Text] [Related]
47. Loss of heterozygosity on chromosome 16p and 18q in anaplastic thyroid carcinoma.
Kadota M; Tamaki Y; Sekimoto M; Fujiwara Y; Aritake N; Hasegawa S; Kobayashi T; Ikeda T; Horii A; Monden M
Oncol Rep; 2003; 10(1):35-8. PubMed ID: 12469141
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
49. Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q.
Al-Mulla F; AlFadhli S; Al-Hakim AH; Going JJ; Bitar MS
J Clin Pathol; 2006 Jun; 59(6):624-30. PubMed ID: 16731603
[TBL] [Abstract][Full Text] [Related]
50. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
51. Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patients.
Popat S; Zhao D; Chen Z; Pan H; Shao Y; Chandler I; Houlston RS
Anticancer Res; 2007; 27(1B):627-33. PubMed ID: 17348452
[TBL] [Abstract][Full Text] [Related]
52. Chromosomal instability (CIN) phenotype, CIN high or CIN low, predicts survival for colorectal cancer.
Watanabe T; Kobunai T; Yamamoto Y; Matsuda K; Ishihara S; Nozawa K; Yamada H; Hayama T; Inoue E; Tamura J; Iinuma H; Akiyoshi T; Muto T
J Clin Oncol; 2012 Jun; 30(18):2256-64. PubMed ID: 22547595
[TBL] [Abstract][Full Text] [Related]
53. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator.
Ogunbiyi OA; Goodfellow PJ; Herfarth K; Gagliardi G; Swanson PE; Birnbaum EH; Read TE; Fleshman JW; Kodner IJ; Moley JF
J Clin Oncol; 1998 Feb; 16(2):427-33. PubMed ID: 9469325
[TBL] [Abstract][Full Text] [Related]
54. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
[TBL] [Abstract][Full Text] [Related]
55. Allelic loss of a common microsatellite marker MYCL1: a useful prognostic factor of poor outcomes in colorectal cancer.
Kambara T; Sharp GB; Nagasaka T; Takeda M; Sasamoto H; Nakagawa H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
Clin Cancer Res; 2004 Mar; 10(5):1758-63. PubMed ID: 15014029
[TBL] [Abstract][Full Text] [Related]
56. Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer.
Carethers JM; Hawn MT; Greenson JK; Hitchcock CL; Boland CR
Gastroenterology; 1998 Jun; 114(6):1188-95. PubMed ID: 9609755
[TBL] [Abstract][Full Text] [Related]
57. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803.
Bertagnolli MM; Redston M; Compton CC; Niedzwiecki D; Mayer RJ; Goldberg RM; Colacchio TA; Saltz LB; Warren RS
J Clin Oncol; 2011 Aug; 29(23):3153-62. PubMed ID: 21747089
[TBL] [Abstract][Full Text] [Related]
58. Loss of heterozygosity in mammary serine protease inhibitor (maspin) and p53 at chromosome 17 and 18 in oral cavity squamous cell carcinoma.
Choi KY; Choi HJ; Chung EJ; Lee DJ; Kim JH; Rho YS
Head Neck; 2015 Sep; 37(9):1239-45. PubMed ID: 24801268
[TBL] [Abstract][Full Text] [Related]
59. Loss of heterozygosity at 3p23 is correlated with poor survival in patients with colorectal carcinoma.
Iniesta P; Massa MJ; González-Quevedo R; de Juan C; Morán A; Sánchez-Pernaute A; Cerdán J; Torres A; Balibrea JL; Benito M
Cancer; 2000 Sep; 89(6):1220-7. PubMed ID: 11002216
[TBL] [Abstract][Full Text] [Related]
60. Characterization and clinical evaluation of microsatellite instability and loss of heterozygosity within tumor-related genes in colorectal cancer.
Huo X; Feng D; Zhang S; Li Z; Li X; Li C; Guo M; Wang J; Zhang Z; Lu Q; Du X; Bai Z; Chen Z
BMC Med Genomics; 2021 Sep; 14(1):235. PubMed ID: 34563193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
